The activation of hypoxia-inducible factor (HIF)-1α under hypoxic conditions promotes EMT in hepatocellular carcinoma (HCC) and induces drug resistance by increasing the expression of MDR1. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.